Early Detection Starts with Comprehensive STI Screening

Sexually transmitted infections (STIs) remain a major global public health challenge. According to the World Health Organization (WHO), strengthening screening and timely diagnosis is essential to reducing the burden of STIs, particularly as many infections can remain asymptomatic and therefore go undetected. WHO's Global Health Sector Strategies on HIV, Viral Hepatitis and STIs also set an ambitious target of reducing new syphilis and gonorrhea infections by 90% by 2030 through improved prevention, testing, and treatment services.

Comprehensive laboratory testing plays a vital role in achieving these goals. Molecular diagnostics enable accurate detection of multiple STI pathogens, supporting earlier diagnosis, timely treatment, and more effective patient management.

At Cowingene, we provide flexible molecular diagnostic solutions to support diverse STI testing needs:

 Cowingene 14 Kinds of Sexually Transmitted Infection Detection Kit

• Simultaneous detection of 14 clinically relevant STI pathogensin a single assay
• Covers bacterial, viral, fungal, and protozoal pathogens associated with sexually transmitted infections
• Supports comprehensive routine STI screening with improved laboratory efficiency

Cowingene STI Multiplex Pro Detection Kit

• A modular molecular diagnostic portfolio designed for comprehensive STI testing
• Offers multiple assay options, including STI Essential Assay, Genital Ulcer Assay, and Candidiasis Assay
• Enables laboratories to select the most appropriate testing solution based on different clinical and diagnostic requirements

By expanding pathogen coverage while maintaining testing flexibility, Cowingene helps laboratories improve diagnostic efficiency and supports more informed clinical decision-making in STI management.

Contact us to learn more about our comprehensive STI molecular diagnostic solutions.

Click to view the LinkedIn post

（https://www.linkedin.com/feed/update/urn:li:activity:7485962648329818112）